{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-002824","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2025-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.867664+00:00","generated_at":"2026-05-27T03:13:05.204009+00:00","sec_items":["2.02","5.07","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Azenta Q1 FY25 revenue rises 4% YoY to $148M; adjusted EBITDA margin improves 400 bps to 9.0%","bullets":["GAAP diluted EPS from continuing ops -$0.21 (vs -$0.13 YoY); total diluted EPS -$0.29 (vs -$0.28).","Non-GAAP diluted EPS unchanged at $0.08; adjusted EBITDA $13M vs $7M in prior year.","Sample Management Solutions revenue $81M (+3% YoY); Multiomics $66M (+6% YoY).","Reaffirmed FY2025 guidance: organic revenue growth 3-5%, adjusted EBITDA margin expansion ~300 bps.","Free cash flow $22M; cash and marketable securities $530M including $27M from discontinued ops."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-002824","json":"https://secwatch.observer/filing/0001437749-25-002824.json","markdown":"https://secwatch.observer/filing/0001437749-25-002824.md","text":"https://secwatch.observer/filing/0001437749-25-002824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000143774925002824/0001437749-25-002824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000143774925002824/azta20241202_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:13:05.204009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}